Richard William Scalzo, SVP, Head of Finance & Administration at Dyne Therapeutics, Inc. (DYN), sold 5,194 shares at $45.01 ($234K) on 2024-08-19, disclosed to the SEC on 2024-08-20.
Scheduled sale ($234k) by SVP, Head of Finance & Administration under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 2,442 | $110K | 47.0% |
| 2 | $45.01 | 2,442 | $110K | 47.0% |
| 3 | $46.00 | 310 | $14K | 6.1% |
| Total | $45.07 avg | 5,194 | $234K | 100% |
| Filing → |
| DYN | SELL | 2025-03-13 | $15K | — | Filing → |
| DYN | SELL | 2025-03-07 | $11K | — | Filing → |
| DYN | SELL | 2025-02-18 | $35K | — | Filing → |